Tianjin Century Healthcare Biomedical Engineering Co., Ltd. (hereinafter referred to as "Century Healthcare ") is a Class III high-end medical device manufacturer integrating R&D, production, and sales. Century Healthcare is located in the West District of Tianjin Development Zone with a GMP factory area of 15,000m2. It established 10,000-level clean production workshop, and high-quality scientific research laboratory equipment with dual water production systems for purified and injection water, as well as an air purification system.Century Healthcare takes " innovative ophthalmic materials and optical design " as its strategic scope, covering fields such as intraocular lenses, optometry, and biomaterial collagen. After more than 10 years of relentless efforts, Century Healthcare has been awarded "National High-Tech Company", “National 'Specialized, Expert, Unique and Innovative' Little Giant Company”，"Tianjin Gazelle Company", ,"Tianjin Strategic Emerging Leading Company", etc. honorary title.Until now, it has been approved as the "Tianjin Key Laboratory of Innovative Ophthalmic Optics Technology", "Graduate Workstation for the Integration of Ophthalmology and Optometry Industry and Education", "Tianjin Central Guiding Local Science and Technology Development Fund Project", "Tianjin Public Health and Biomedical Technology Major Special Project" and other honors and project support.And our company has been selected as a key cultivated listed enterprise in Tianjin Binhai New Area.
Century Healthcare adheres to the principle of “Focusing on core medical technologies and continuously upgrading optical solutions" and currently has more than 20 products applied in ophthalmology, surgery, medical aesthetics, and other fields. The company has obtained over 80 invention patents and utility model patents, with approvals from the National Medical Products Administration for 11 Class III medical device registration certificates and 3 Class II medical device registration certificates.Additionally, the intraocular lens had obtained foreign certifications such as CE certification. It is one of the few domestic companies in the ophthalmology field that simultaneously possesses core technologies in hydrophilic, hydrophobic, single-focus, and multifocal artificial lens optical design, processing, and production. Among its innovations, the"-0.1μm Spherical Aberration Design," "Edge-Enhanced Zero Spherical Aberration," "Hollow Loop," and "625 Large Optical Zone" are the first aspheric intraocular lenses in China. The world's first and domestically pioneering triple focus Plus artificial lens was approved through the "Special Review Procedure for Innovative Medical Devices" in October 2023, becoming the first innovative triple focus artificial lens product in China; The depth of field extended intraocular lens was approved through the "Special Review Procedure for Innovative Medical Devices" in April 2024. Our company is the only domestic manufacturer to have obtained the "Double Innovation" medical device special review procedures for the two high-end lenses mentioned above. In the field of optometry, defocusing lenses, RGP, and the domestically first second-generation non spherical scleral lens have all been launched.The collagen sponge obtained the first Class III medical device registration certificate for surgical use of collagen sponge under the new standards approved by the National Medical Products Administration since 2011.
Century Healthcare currently owns 5 wholly-owned subsidiaries responsible for the research and development, production, sales, and related services of its products.At the same time, our company is also the first domestic enterprise to have implantable collagen raw materials and products covering a full range of surgical, dermatological, and functional skincare products.
Since the launch of the company's independently developed intraocular lens product in 2020, it has solved the problem of cataract disease for nearly million people.
Currently, hydrophilic aspherical intraocular lenses and hydrophobic preloaded intraocular lenses have won the bid for the fourth batch of centralized procurement of medical consumables organized by the state. The products are used in nearly 2,000 hospitals across the country, with a good market reputation and extensive clinical applications.
Class III high-end medical device manufacturer that integrate research and development, production, and sales
Vision, mission, values, and business philosophy
On January 6, 2024, the industrial construction project (Phase II) factory completed acceptance inspection.
On January 16, 2024, Century Healthcare was listed for the first time on the "2023 Venture50 Investment Life and Health Enterprises" list.
In February 2024, Century Healthcare participated in APAO2024 and launched its international market business expansion officially.
On March 8, 2024, Century Healthcare donated 830 intraocular lenses to support the "Peng Nian Bright Action".
On March 29, 2024, the company and Tanggu Maternity and Gynecology Hospital in Binhai New Area, Tianjin jointly applied for the "Central Guidance for Local Science and Technology Development Fund" project, which was successfully completed.
On April 19, 2024, depth of field extended intraocular lens (EDOF) from the company's independently developed was approved as an innovative medical device.
On July 30, 2024, new generation pre-assembled universal hydrophobic intraocular lens from the company's independently developed was selected for the tenth batch of "Excellent Domestic Medical Equipment Product Catalog".
In August 2024, the Century Healthcare hydrophilic non-spherical intraocular lens was approved by the State Administration for Market Regulation to add negative power, and the optical power range was changed from the original "+5.0D to+30.0D, with an optical power interval of 0.5D" to "-10.0D to+30.0D, with an optical power interval of 0.5D".
On August 22, 2024, we obtained the registration certificate for rigid breathable scleral contact lenses (registration number: 20243161538) .
On September 2, 2024, it was awarded the title of National Specialized, Refined, Unique and New "Little Giant" Enterprise.
In September 2024, Century Healthcare was honored as the drafting unit for the group standard release of the "Corneal Plastic Mirror Fitting Regulations".
On September 22, 2024, the company moved into a new residence and the second phase of the office building was officially put into use.
In November 2024, collagen sponge was added with new specifications specifically for oral, otolaryngology.
In December 2024, the Century Healthcare Multi level Depth of Field Extended intraocular Lens was selected for the Tianjin Science and Technology Major Special Project List.
In April 2023, the joint construction of the Ophthalmology and Ophthalmic Optics Industry Education Integration Graduate Workstation with the Ophthalmology Hospital of Tianjin Medical University was approved.
In April 2023, tens of millions of A+rounds of financing were completed, led by Haihe Industrial Fund.
In April 2023, the wholly-owned subsidiary Century Healthcare (Dongguan) Medical Technology Co., Ltd. was established.
In May 2023, we were awarded the honorary title of Specialized, Refined, Unique, and New Small and Medium sized Enterprise in Tianjin.
In June 2023, the Academic Exchange and Training Base for Grassroots Ophthalmologists jointly established by Tianjin Medical University Ophthalmology Hospital, Tianjin Medical University Ophthalmology Vocational Training School, and Tianjin Century Healthcare Biomedical Engineering Co., Ltd. officially landed.
On July 12, 2023, obtained the registration certificate for hydrophobic aspherical pre installed intraocular lenses (NMPA certificate No.20233160956).
September 2023, hundreds of millions of yuan in Series B financing were completed, led by Guotou Chuanghe Fund.
On October 13, 2023, Century Healthcare 's asymmetric and full field of view multifocal intraocular lens officially entered the special device review process of the National Medical Products Administration for innovation.
On October 23, 2023, obtained the registration certificate for hydrophobic aspherical non pre installed intraocular lenses (NMPA certificate No.20233161502).
On November 30, 2023, Century Healthcare 's intraocular lens won the bid for the fourth batch of national organized procurement of high-value medical consumables.
In November 2023, the "Central Guiding Local Science and Technology Development Fund" innovative ophthalmic materials and optical design technology innovation project was approved.
On December 18, 2023, the collagen dressing produced by Hainan Amily Biotechnology Co.,Ltd, a subsidiary of Century Healthcare, was approved by NMPA .
In May 2022, the wholly-owned subsidiary Century Kangsheng (Shenzhen) Biomedical Engineering Co., Ltd. was established.
In May 2022, tens of millions of A rounds of financing were completed.
In August 2022, the company was listed on the list of "China's 10 fold growth potential medical enterprises" initiated by 36Kr.
In August 2022, it was awarded the title of Excellent Enterprise in the "Maker China" National Biomedical Group Competition and Excellent Enterprise in the Tianjin Division.
In September 2022, it was selected as the second batch of key cultivated listed enterprise reserve resource storage enterprises in Tianjin.
In October 2022, the wholly-owned subsidiary Century Healthcare (Zhuhai Hengqin) Technology Co., Ltd. was established.
In November 2022, the independently developed hydrophilic spherical foldable intraocular lens won the third prize of the Tianjin Science and Technology Progress Award.
In November 2022, the first "Diffractive Multi focus Artificial Lens Project" in China won the first prize in the Biomedical Growth Group of the 2022 Tianjin Innovation and Entrepreneurship Competition and the honorary title of "Excellent Enterprise" in the 11th China Innovation and Entrepreneurship Competition.
In December 2022, the Tianjin Innovative Ophthalmic Optics Technology Key Laboratory, jointly established with the Eye Hospital of Tianjin Medical University, was successfully approved for establishment.
In December 2022, the rigid breathable corneal contact lens was approved for sale with registration (NMPA certificate No. 20223161413).
On January 30, 2021, the industrial transformation cooperation base with the Eye Hospital of Tianjin Medical University was unveiled.
On March 10, 2021, obtained the registration certificate for hydrophilic aspherical intraocular lenses (registration number: NMPA certificate No. 20213160173).
On March 26, 2021, we obtained the third batch of key enterprise qualifications for the "Tianjin Seed" enterprise cultivation plan from the Tianjin Municipal Bureau of Industry and Information Technology and the Tianjin Small and Medium sized Enterprise Credit Financing Guarantee Center, as well as a financing guarantee credit limit of 30 million yuan from the Tianjin Small and Medium sized Enterprise Credit Financing Guarantee Center.
On May 18, 2021, the cosmetics production license was approved, officially entering the field of collagen beauty and skincare.
On July 23, 2021, Hainan Aimei Biotechnology Co., Ltd., a wholly-owned subsidiary, was established.
On August 5, 2021, it was awarded the title of "Specialized, Refined, Unique and New" Seed Enterprise by the Tianjin Municipal Bureau of Industry and Information Technology.
On December 2021, it was selected as a leading enterprise in Tianjin's strategic emerging industries.
On December 2021, it was selected as a "Tianjin Gazelle Enterprise" database.
On January 8, 2020, the wholly-owned subsidiary Century Healthcare (Tianjin) Technology Development Co., Ltd. was established.
On February 12, 2020, obtained the EU CE registration certificate for foldable intraocular lens products.
On March 11, 2020, obtained the collagen sponge registration certificate (NMPA certificate No. 20203140216).
On March 20, 2020, obtained the registration certificate for hydrophilic spherical foldable intraocular lenses (NMPA certificate No. 20203160297).
On April 9, 2020, obtained the registration certificate for disposable ophthalmic surgical knives (NMPA certificate No. 20202160095).
In 2020, hydrophilic spherical foldable intraocular lenses won consecutive bids in the joint volume procurement of medical consumables (artificial lenses) in the Beijing Tianjin Hebei, Heilongjiang Jilin Liaoning Inner Mongolia Shanxi Shandong, and Shaanxi inter provincial alliance, officially entering the centralized procurement sequence of artificial lenses.
In December 2020, we established a comprehensive cooperative relationship with the School of Electronic Information and Optical Engineering of Nankai University, and established an industry university research innovation base.
National High-Tech Company
National "Specialized, Expert, Unique and Innovative" Little Giant Company
Tianjin Gazelle Company
Century Healthcare
Meishiji
Ordinary Skincare
